US2006002897A1PendingUtilityA1

Vectors for tissue-specific replication

65
Assignee: HALLENBECK PAUL LPriority: Nov 28, 1994Filed: Sep 2, 2005Published: Jan 5, 2006
Est. expiryNov 28, 2014(expired)· nominal 20-yr term from priority
A61K 48/0058C12N 2830/85C12N 2830/008C12N 2710/10343C12N 2820/002A61K 48/00A61P 43/00C12N 2830/32C12N 15/86C12N 2830/002A61P 35/00C12N 2840/20
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention generally relates to targeted gene therapy using recombinant vectors and particularly adenovirus vectors. The invention specifically relates to replication-conditional vectors and methods for using them. Such vectors are able to selectively replicate in a target tissue to provide a therapeutic benefit from the presence of the vector per se or from heterologous gene products expressed from the vector and distributed throughout the tissue. In such vectors, a gene essential for replication is placed under the control of a heterologous tissue-specific transcriptional regulatory sequence. Thus, replication is conditioned on the presence of a factor(s) that induces transcription or the absence of a factor(s) that inhibits transcription of the gene by means of the transcriptional regulatory sequence with this vector; therefore, a target tissue can be selectively treated.

Claims

exact text as granted — not AI-modified
1 . A vector capable of tissue-specific replication comprising: 
 a tissue-specific transcriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector.    
     
     
         2 - 40 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.